Parasite polyclonal activators: new targets for vaccination approaches?
about
Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling PathwaysEvasion of the Immune Response by Trypanosoma cruzi during Acute InfectionPhylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite evasion from host defences.Differential regional immune response in Chagas diseaseIgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India.BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.Acute chagas disease: new global challenges for an old neglected diseaseTumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria.The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infectionA B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.B-Cell Response during Protozoan Parasite InfectionsInnate and acquired immunity in the pathogenesis of Chagas disease.Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.Chagas heart disease pathogenesis: one mechanism or many?Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial.Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection.T-bet-dependent regulation of CD8+ T-cell expansion during experimental Trypanosoma cruzi infection.Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites.Anti-band 3 and anti-spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia.
P2860
Q26749609-507D7C18-550C-414A-B143-8C4D0EF00B99Q26772721-8ECBA1C6-6701-449B-99C8-4C596FCE6A8AQ30936576-418C0FEC-486E-42DD-B6D3-2A829EDEB2A7Q33479115-52B12754-FCD6-446D-A51A-C4536ED189B7Q33518569-F8A545FC-0EE2-4A91-9C47-221090731D76Q33573335-EE71F9BE-8EB0-4087-A32A-81EA83E55A5BQ33631293-88FD6C2A-9C9E-488C-949B-D3FA241780C9Q33981753-D1B9BC89-F110-43FB-9330-C8BA833D1AACQ34032964-8DD777EF-32D5-4DD5-98EA-C766D08993F0Q34090268-9AC47336-6153-45C2-A988-5B3E3477C5B6Q34221892-B99C112F-B4AF-488E-B77A-EEE280483419Q34385087-2CC04432-6955-45AD-A2D7-05347543C438Q35133901-B93A9CC1-257C-4E46-B8A1-A21536538F37Q35725257-729121EE-4B01-4CE0-B25F-8718FCF19A89Q35994773-A9942642-0500-4018-92FA-57A4B11C0F50Q36385476-63EFAFAA-DBFE-43EF-82E8-80D44FF69004Q37145013-8880C99E-77A5-4E75-B010-EA55CF1CFBC4Q37264799-23D643BC-78B6-40FE-BE63-E04F7273B3A8Q39146653-A7169214-F727-4B90-B44A-9288EF6673A2Q41552272-47FAE6EB-02C3-48A6-A431-688509D95172Q43169575-75E5A468-DC18-4FEF-B099-DA22B92953B5Q43640153-37EE4B3A-77EF-43B3-AF94-DA30AE0A48BCQ54648155-366A250F-299E-41D1-AD5A-365A764246D3Q55426170-88E0B0CE-815A-4F2C-BB48-17C6735A1FC6
P2860
Parasite polyclonal activators: new targets for vaccination approaches?
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Parasite polyclonal activators: new targets for vaccination approaches?
@ast
Parasite polyclonal activators: new targets for vaccination approaches?
@en
Parasite polyclonal activators: new targets for vaccination approaches?
@nl
type
label
Parasite polyclonal activators: new targets for vaccination approaches?
@ast
Parasite polyclonal activators: new targets for vaccination approaches?
@en
Parasite polyclonal activators: new targets for vaccination approaches?
@nl
prefLabel
Parasite polyclonal activators: new targets for vaccination approaches?
@ast
Parasite polyclonal activators: new targets for vaccination approaches?
@en
Parasite polyclonal activators: new targets for vaccination approaches?
@nl
P1476
Parasite polyclonal activators: new targets for vaccination approaches?
@en
P2093
Minoprio P
P304
P356
10.1016/S0020-7519(01)00171-0
P577
2001-05-01T00:00:00Z